KONINKLIJKE PHILIPS NV (PHIA.AS)
NL0000009538 - Common Stock
PHIA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 57 industry peers in the Health Care Equipment & Supplies industry. PHIA may be in some trouble as it scores bad on both profitability and health. PHIA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year PHIA was profitable.
In the past year PHIA had a positive cash flow from operations.
In multiple years PHIA reported negative net income over the last 5 years.
PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
PHIA's Return On Assets of -1.58% is in line compared to the rest of the industry. PHIA outperforms 44.44% of its industry peers.
PHIA's Return On Equity of -3.87% is in line compared to the rest of the industry. PHIA outperforms 46.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.58% | ||
| ROE | -3.87% | ||
| ROIC | N/A |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHIA's Operating Margin has declined in the last couple of years.
The Gross Margin of PHIA (41.00%) is worse than 72.22% of its industry peers.
PHIA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for PHIA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41% |
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
2. Health
2.1 Basic Checks
PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PHIA has less shares outstanding
PHIA has less shares outstanding than it did 5 years ago.
The debt/assets ratio for PHIA is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.54, we must say that PHIA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.54, PHIA is in line with its industry, outperforming 42.59% of the companies in the same industry.
The Debt to FCF ratio of PHIA is 4.76, which is a neutral value as it means it would take PHIA, 4.76 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 4.76, PHIA is doing good in the industry, outperforming 75.93% of the companies in the same industry.
A Debt/Equity ratio of 0.58 indicates that PHIA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.58, PHIA is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | 4.76 | ||
| Altman-Z | 1.54 |
ROIC/WACCN/A
WACC6.19%
2.3 Liquidity
PHIA has a Current Ratio of 1.20. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.20, PHIA is not doing good in the industry: 70.37% of the companies in the same industry are doing better.
PHIA has a Quick Ratio of 1.20. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of PHIA (0.78) is worse than 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 30.53% over the past year.
The Earnings Per Share has been decreasing by -2.67% on average over the past years.
The Revenue has been growing slightly by 1.92% in the past year.
PHIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.05% yearly.
EPS 1Y (TTM)30.53%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS growth Q2Q0%
Revenue 1Y (TTM)1.92%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Revenue growth Q2Q-6.64%
3.2 Future
Based on estimates for the next years, PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.30% on average per year.
The Revenue is expected to grow by 4.66% on average over the next years.
EPS Next Y8.91%
EPS Next 2Y13.09%
EPS Next 3Y12.64%
EPS Next 5Y17.3%
Revenue Next Year1.66%
Revenue Next 2Y3.34%
Revenue Next 3Y3.85%
Revenue Next 5Y4.66%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
PHIA is valuated correctly with a Price/Earnings ratio of 15.88.
87.04% of the companies in the same industry are more expensive than PHIA, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 25.20. PHIA is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 14.58, which indicates a correct valuation of PHIA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PHIA indicates a rather cheap valuation: PHIA is cheaper than 81.48% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of PHIA to the average of the S&P500 Index (21.60), we can say PHIA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.88 | ||
| Fwd PE | 14.58 |
4.2 Price Multiples
PHIA's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHIA indicates a rather cheap valuation: PHIA is cheaper than 90.74% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.05 | ||
| EV/EBITDA | 20.42 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PHIA's earnings are expected to grow with 12.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.78
PEG (5Y)N/A
EPS Next 2Y13.09%
EPS Next 3Y12.64%
5. Dividend
5.1 Amount
No dividends for PHIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
KONINKLIJKE PHILIPS NV
AMS:PHIA (4/24/2024, 11:20:17 AM)
19.69
+0.09 (+0.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap17.85B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.88 | ||
| Fwd PE | 14.58 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.78
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.58% | ||
| ROE | -3.87% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)30.53%
EPS 3Y-15.7%
EPS 5Y
EPS growth Q2Q
EPS Next Y8.91%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1.92%
Revenue growth 3Y1.62%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y